Position in HLN
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$365,144
-$797 QoQ
Shares Held
36,478
+0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026SBI Securities Co., Ltd. holds $3,193,853 across 54 Drug Manufacturers - Specialty & Generic names. HLN ranks #4 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
41,929 | $870,446 | |
| 2 | CGC |
Canopy Growth Corp
|
616,868 | $585,407 | |
| 3 | ZTS |
Zoetis Inc.
|
3,493 | $412,907 | |
| 4 | HLN |
Haleon plc
This page
|
36,478 | $365,144 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
409 | $242,528 | |
| 6 | VTRS |
Viatris Inc
|
17,404 | $235,128 | |
| 7 | TLRY |
Tilray Brands, Inc.
|
25,785 | $166,828 | |
| 8 | AQST |
Aquestive Therapeutics, Inc.
|
17,805 | $73,890 |
All Filings in HLN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $365,144 | 36,478 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $365,941 | 36,196 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $324,552 | 36,182 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $381,087 | 36,749 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $387,655 | 37,673 | Shares | Defined | 2025-05-02 | |
| 2024-12-31 | $353,123 | 37,015 | Shares | Defined | 2025-02-06 | |
| No filing history on record for this holder in this stock. | ||||||